Moreover, the interaction between VLA-4 on AML cells and FN on stromal cells results in the activation of the phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt)/Bcl-2 signaling pathway and, ultimately, resistance to chemotherapy-induced apoptosis. The gene discussed is AKT1; the disease is acute myeloid leukemia.